•
Mar 31, 2023

Prosperity Q1 2023 Earnings Report

Reported net income of $124.7 million and EPS of $1.37.

Key Takeaways

Prosperity Bancshares, Inc. reported a net income of $124.7 million for the quarter ended March 31, 2023, compared to $122.3 million for the same period in 2022. The diluted earnings per share were $1.37, up from $1.33 in the previous year. Loans, excluding Warehouse Purchase Program loans, increased by $436.0 million, and nonperforming assets remained low at 0.07% of average interest-earning assets.

Net income for the first quarter was $124.7 million, with earnings per share (diluted) at $1.37.

Loans, excluding Warehouse Purchase Program loans, increased by $436.0 million, representing a 2.4% increase during the first quarter of 2023.

The allowance for credit losses on loans to total loans, excluding Warehouse Purchase Program loans, was 1.52%.

Nonperforming assets remained low, accounting for 0.07% of first quarter average interest-earning assets.

Total Revenue
$282M
Previous year: $275M
+2.4%
EPS
$1.37
Previous year: $1.33
+3.0%
Efficiency Ratio
43.68%
Previous year: 43.68%
+0.0%
Cash and Equivalents
$405M
Previous year: $1.56B
-74.0%
Free Cash Flow
$170M
Previous year: $212M
-20.2%
Total Assets
$37.8B
Previous year: $38.3B
-1.2%

Prosperity

Prosperity

Forward Guidance

Prosperity has established lines of credit at the Federal Home Loan Bank and the Federal Reserve in the amount of $14.7 billion, of which $11.3 billion is currently available.

Positive Outlook

  • Talented team
  • Deep bench
  • Strong earnings
  • Solid capital position
  • Fortress balance sheet

Challenges Ahead

  • Market was flooded with excess funds the last few years during the COVID-19 pandemic
  • Federal Reserve is reducing the money supply in its efforts to lower inflation
  • Most banks saw a loss of deposits during the quarter
  • Some customers who were concerned with liquidity after the failure of SVB and Signature Bank
  • Market was flooded with excess funds the last few years during the COVID-19 pandemic